IL22 and hepatocellular carcinoma: To investigate the effects of the cytokine IL-22 and its natural inhibitor IL-22BP during HCC development, we applied a well-known chemical model of HCC induction to C57BL/6-, IL22-/--, and IL22bp-/--mice.